Abstract
Background
The successful application of ex vivo liver resection and autotransplantation (ERAT) has gained widespread attention for the treatment of end-stage hepatic alveolar echinococcosis, which is considered to be unresectable by conventional methods due to extensive invasion of the extra- and intrahepatic vasculature. However, data on remnant liver volume (RLV) are limited, and the safe volume limit of remnant liver is still unclear.
Methods
To determine the effect of liver volume in the technically developed era, we investigated the impact of the remnant liver-to-standard liver volume ratio (RLV/SLV) on the outcomes of ERAT.
Results
From February 2014 to May 2018, 56 ERAT procedures were performed. Eleven patients with an RLV/SLV < 40% (group S) were compared with 45 patients with an RLV/SLV ≥ 40% (group L). Serial changes in postoperative serum total bilirubin, alanine aminotransferase, aspartate aminotransferase, and international normalized ratio were comparable in both groups. The incidences of postoperative complications did not significantly differ between the two groups. Three patients died of intra-abdominal bleeding, acute cerebral hemorrhage, and severe liver dysfunction. In RLV estimation analysis, the actual RLV and RLV/SLV were significantly smaller than the expected RLV and RLV/SLV as determined by preoperative three-dimensional reconstruction software in patients with hepatic venous outflow obstruction.
Conclusion
Patients with a smaller RLV/SLV did not have outcomes inferior to those with a larger RLV/SLV. Further studies are warranted to clarify the factors that contribute to preoperative volumetric estimation and the safe lower limits for ERAT.
Similar content being viewed by others
References
Conraths FJ, Probst C, Possenti A, Boufana B, Saulle R, La Torre G, Busani L, Casulli A. Potential risk factors associated with human alveolar echinococcosis: systematic review and meta-analysis. PLoS neglected tropical diseases. 2017;11(7):e0005801.
Vuitton DA, Zhou H, Bresson-Hadni S, Wang Q, Piarroux M, Raoul F, Giraudoux P. Epidemiology of alveolar echinococcosis with particular reference to China and Europe. Parasitology. 2003;127 Suppl:S87–107.
Brunetti E, Kern P, Vuitton DA. Expert consensus for the diagnosis and treatment of cystic and alveolar echinococcosis in humans. Acta tropica. 2010;114(1):1–16.
Aydinli B, Ozturk G, Arslan S, Kantarci M, Tan O, Ahiskalioglu A, Ozden K, Colak A. Liver transplantation for alveolar echinococcosis in an endemic region. Liver Transpl. 2015;21(8):1096–1102.
Yang X, Qiu Y, Huang B, Wang W, Shen S, Feng X, Wei Y, Lei J, Zhao J, Li B, Wen T, Yan L. Novel techniques and preliminary results of ex vivo liver resection and autotransplantation for end-stage hepatic alveolar echinococcosis: a study of 31 cases. American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2018;18(7):1668–1679.
Jianyong L, Jingcheng H, Wentao W, Lunan Y, Jichun Z, Bing H, Ding Y. Ex vivo liver resection followed by autotransplantation to a patient with advanced alveolar echinococcosis with a replacement of the retrohepatic inferior vena cava using autogenous vein grafting: a case report and literature review. Medicine (Baltimore). 2015;94(7):e514.
Miller CM, Quintini C, Dhawan A, Durand F, Heimbach JK, Kim-Schluger HL, Kyrana E, Lee SG, Lerut J, Lo CM, Pomfret EA. The International Liver Transplantation Society Living Donor Liver Transplant Recipient Guideline. Transplantation. 2017;101(5):938–944.
Sugawara Y, Makuuchi M, Takayama T, Imamura H, Dowaki S, Mizuta K, Kawarasaki H, Hashizume K. Small-for-size grafts in living-related liver transplantation. J Am Coll Surg. 2001;192(4):510–513.
Pak LM, Chakraborty J, Gonen M, Chapman WC, Do RKG, Groot Koerkamp B, Verhoef K, Lee SY, Massani M, van der Stok EP, Simpson AL, Memorial Sloan Kettering Cancer Center Hepatopancreatobiliary S. Quantitative imaging features and postoperative hepatic insufficiency: a multi-institutional expanded cohort. J Am Coll Surg. 2018;226(5):835–843.
Kim HJ, Kim CY, Park EK, Hur YH, Koh YS, Kim HJ, Cho CK. Volumetric analysis and indocyanine green retention rate at 15 min as predictors of post-hepatectomy liver failure. HPB: the official journal of the International Hepato Pancreato Biliary Association. 2015;17(2):159–167.
Schindl MJ, Redhead DN, Fearon KC, Garden OJ, Wigmore SJ, Edinburgh Liver S, Transplantation Experimental Research G. The value of residual liver volume as a predictor of hepatic dysfunction and infection after major liver resection. Gut. 2005;54(2):289–296.
He YB, Bai L, Jiang Y, Ji XW, Tai QW, Zhao JM, Zhang JH, Liu WY, Wen H. Application of a three-dimensional reconstruction technique in liver autotransplantation for end-stage hepatic alveolar echinococcosis. J Gastrointest Surg. 2015;19(8):1457–1465.
He YB, Bai L, Aji T, Jiang Y, Zhao JM, Zhang JH, Shao YM, Liu WY, Wen H. Application of 3D reconstruction for surgical treatment of hepatic alveolar echinococcosis. World Journal of Gastroenterology. 2015;21(35):10200–10207.
Radtke A, Sotiropoulos GC, Nadalin S, Molmenti EP, Schroeder T, Lang H, Saner F, Valentin-Gamazo C, Frilling A, Schenk A, Broelsch CE, Malago M. Preoperative volume prediction in adult living donor liver transplantation: how much can we rely on it? American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2007;7(3):672–679.
Baskiran A, Kahraman AS, Cicek IB, Sahin T, Isik B, Yilmaz S. Preoperative evaluation of liver volume in living donor liver transplantation. Northern clinics of Istanbul. 2018;5(1):1–5.
Hiroshige S, Shimada M, Harada N, Shiotani S, Ninomiya M, Minagawa R, Soejima Y, Suehiro T, Honda H, Hashizume M, Sugimachi K. Accurate preoperative estimation of liver-graft volumetry using three-dimensional computed tomography. Transplantation. 2003;75(9):1561–1564.
Urata K, Kawasaki S, Matsunami H, Hashikura Y, Ikegami T, Ishizone S, Momose Y, Komiyama A, Makuuchi M. Calculation of child and adult standard liver volume for liver transplantation. Hepatology (Baltimore, Md). 1995;21(5):1317–1321.
Moriyasu F, Ban N, Nishida O, Nakamura T, Miyake T, Uchino H, Kanematsu Y, Koizumi S. Clinical application of an ultrasonic duplex system in the quantitative measurement of portal blood flow. Journal of clinical ultrasound: JCU. 1986;14(8):579–588.
Guidelines for treatment of cystic and alveolar echinococcosis in humans. WHO Informal Working Group on Echinococcosis. Bulletin of the World Health Organization. 1996;74(3):231–242.
Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, de Santibanes E, Pekolj J, Slankamenac K, Bassi C, Graf R, Vonlanthen R, Padbury R, Cameron JL, Makuuchi M. The Clavien–Dindo classification of surgical complications: five-year experience. Annals of surgery. 2009;250(2):187–196.
Dahm F, Georgiev P, Clavien PA. Small-for-size syndrome after partial liver transplantation: definition, mechanisms of disease and clinical implications. Am J Transplant. 2005;5(11):2605–2610.
Deplazes P, Rinaldi L, Alvarez Rojas CA, Torgerson PR, Harandi MF, Romig T, Antolova D, Schurer JM, Lahmar S, Cringoli G, Magambo J, Thompson RC, Jenkins EJ. Global distribution of alveolar and cystic echinococcosis. Advances in parasitology. 2017;95:315–493.
Wen H, Dong JH, Zhang JH, Zhao JM, Shao YM, Duan WD, Liang YR, Ji XW, Tai QW, Aji T, Li T. Ex vivo liver resection followed by autotransplantation for end-stage hepatic alveolar echinococcosis. Chinese medical journal. 2011;124(18):2813–2817.
Wen H, Dong JH, Zhang JH, Duan WD, Zhao JM, Liang YR, Shao YM, Ji XW, Tai QW, Li T, Gu H, Tuxun T, He YB, Huang JF. Ex vivo liver resection and autotransplantation for end-stage alveolar echinococcosis: a case series. American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2016;16(2):615–624.
Wang H, Liu Q, Wang Z, Zhang F, Li X, Wang X. Clinical outcomes of ex vivo liver resection and liver autotransplantation for hepatic alveolar echinococcosis. Journal of Huazhong University of Science and Technology Medical sciences = Hua zhong ke ji da xue xue bao Yi xue Ying De wen ban = Huazhong keji daxue xuebao Yixue Yingdewen ban. 2012;32(4):598–600.
Rammohan A, Govil S, Vargese J, Kota V, Reddy MS, Rela M. Changing pattern of biliary complications in an evolving liver transplant unit. Liver Transpl. 2017;23(4):478–486.
Ikegami T, Yoshizumi T, Sakata K, Uchiyama H, Harimoto N, Harada N, Itoh S, Nagatsu A, Soejima Y, Maehara Y. Left lobe living donor liver transplantation in adults: what is the safety limit? Liver Transpl. 2016;22(12):1666–1675.
Zhang W, Tan Y, Shen S, Jiang L, Yan L, Yang J, Li B, Wen T, Zeng Y, Wang W, Xu M. Adult to adult right lobe living donor liver transplantation: does biological relationship matter? Medicine (Baltimore). 2017;96(4):e4139.
Yao S, Kaido T, Uozumi R, Yagi S, Miyachi Y, Fukumitsu K, Anazawa T, Kamo N, Taura K, Okajima H, Uemoto S. Is portal venous pressure modulation still indicated for all recipients in living-donor liver transplantation? Liver Transpl. 2018.
Uemura T, Wada S, Kaido T, Mori A, Ogura Y, Yagi S, Fujimoto Y, Ogawa K, Hata K, Yoshizawa A, Okajima H, Uemoto S. How far can we lower graft-to-recipient weight ratio for living donor liver transplantation under modulation of portal venous pressure? Surgery. 2016;159(6):1623–1630.
Kiuchi T, Tanaka K, Ito T, Oike F, Ogura Y, Fujimoto Y, Ogawa K. Small-for-size graft in living donor liver transplantation: how far should we go? Liver Transpl. 2003;9(9):S29–35.
Chang CD, Cheng YF, Chen TY, Tsang LL, Ou HY, Yu CY, Hsu HW, Chen CL, Concejero AM, Huang TL. Portal venous pressure in adult living donor liver transplantation. Transplantation proceedings. 2014;46(3):696–698.
Troisi R, Cammu G, Militerno G, De Baerdemaeker L, Decruyenaere J, Hoste E, Smeets P, Colle I, Van Vlierberghe H, Petrovic M, Voet D, Mortier E, Hesse UJ, de Hemptinne B. Modulation of portal graft inflow: a necessity in adult living-donor liver transplantation? Ann Surg. 2003;237(3):429–436.
Acknowledgements
The authors thank American Journal Experts for language editing.
Author information
Authors and Affiliations
Contributions
Study conception and design: W. T.W.
Acquisition of data: S.S., Y.W.Q., X.W.Y.
Analysis and interpretation of data: S.S., Y.W.Q.
Drafting of manuscript: S.S., Y.W.Q.
Critical revision: W.T.W.
Corresponding author
Ethics declarations
Disclosure
Supported by grants of the National Natural Science Foundation of China (no. 81770566), the New Medical Technology Foundation of West China Hospital of Sichuan University (no. 2016-036), and the Department of Science and Technology of Sichuan Province (no. 2016FZ0076).
Disclosure Information
Nothing to disclose.
Rights and permissions
About this article
Cite this article
Shen, S., Qiu, Y., Yang, X. et al. Remnant Liver-to-Standard Liver Volume Ratio Below 40% is Safe in Ex Vivo Liver Resection and Autotransplantation. J Gastrointest Surg 23, 1964–1972 (2019). https://doi.org/10.1007/s11605-018-4022-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11605-018-4022-4